12:00 AM
 | 
Oct 01, 2012
 |  BC Week In Review  |  Company News  |  Other News

Actinium cancer news

Actinium engaged investment bank and brokerage firm Laidlaw & Co. Ltd. to assist the biotech in going public on a U.S. stock exchange later this year. The company intends to raise $20 million through...

Read the full 147 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >